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Background: Excessive and inappropriate antibiotic use contributes to growing antibiotic resistance, an important
public-health problem. Strategies must be developed to improve antibiotic-prescribing. Our purpose is to review of
educational programs aimed at improving antibiotic-prescribing by physicians and/or antibiotic-dispensing by
pharmacists, in both primary-care and hospital settings.
Methods: We conducted a critical systematic search and review of the relevant literature on educational
programs aimed at improving antibiotic prescribing and dispensing practice in primary-care and hospital settings,
published in January 2001 through December 2011.
Results: We identified 78 studies for analysis, 47 in primary-care and 31 in hospital settings. The studies differed widely
in design but mostly reported positive results. Outcomes measured in the reviewed studies were adherence to
guidelines, total of antibiotics prescribed, or both, attitudes and behavior related to antibiotic prescribing and
quality of pharmacy practice related to antibiotics. Twenty-nine studies (62%) in primary care and twenty-four (78%) in
hospital setting reported positive results for all measured outcomes; fourteen studies (30%) in primary care and six
(20%) in hospital setting reported positive results for some outcomes and results that were not statistically influenced
by the intervention for others; only four studies in primary care and one study in hospital setting failed to report
significant post-intervention improvements for all outcomes. Improvement in adherence to guidelines and decrease of
total of antibiotics prescribed, after educational interventions, were observed, respectively, in 46% and 41% of all the
reviewed studies. Changes in behaviour related to antibiotic-prescribing and improvement in quality of pharmacy
practice was observed, respectively, in four studies and one study respectively.
Conclusion: The results show that antibiotic use could be improved by educational interventions, being mostly
used multifaceted interventions.
Keywords: Drug resistance microbial, Review, Behavior change, Education medical continuing, Education
pharmacy continuingBackground
Antibiotic resistance is an important public-health issue,
which is aggravated by the lack of new antimicrobial
agents [1,2]. Inappropriate use of antibiotics is the main
factor underlying microbial resistance [3,4]. Ecological
studies in Europe suggest that there is a clear association* Correspondence: teresaherdeiro@ua.pt
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unless otherwise stated.between extent of antibiotic use and rate of resistance
[5]. Excessive and inappropriate use of antibiotics is
attributed to misprescription and to self-medication with
“leftovers” from previous courses or with antibiotics
dispensed in pharmacies without prescription [6,7]. In
countries with a high incidence of self-medication with
antibiotics, prescription of antibiotics is also high [7],
suggesting that both practices are subject to the same
cultural factors [8]. Physicians and pharmacists are
the health professionals who exert most influence on
patients’ medication-related behavior. Many educational
interventions to improve antibiotic-prescribing and/orThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vious systematic reviews of the topic include Steinman’s
[9], which covered reports published prior to 2004 and
on interventions directed at physicians. Other more re-
cent reviews [10-13] have targeted specific areas, namely,
respiratory tract infections [10,13], critical care [11], and
acute care [12]. Therefore, there has been no general
reviews, of the topic, including interventions on physicians
a pharmacists to improve antibiotic prescription and dis-
pensing. To close this gap, we carried out a critical review
of educational programs aimed at improving antibiotic-
prescribing by physicians and/or antibiotic-dispensing by
pharmacists, in both primary-care and hospital settings.
Methods
Literature search methodology
For review purposes, we conducted a search of the
MEDLINE-PubMED scientific database from January
2001 through December 2011. In addition, other papers
were located by manual searches targeting journals,
particularly those less likely to be indexed, and refer-
ences cited by papers retrieved.
The search strategy was designed to identify relevant
studies addressing antibiotic resistance and the prescrib-
ing/dispensing habits of health care providers (physicians
and pharmacists) pre- and post-educational interven-
tions. The following search terms and their equivalents
were used in PubMed: (“intervention” OR “program”
OR “health promotion” OR “education”) AND (“phar-
macists” OR “pharmacy” OR “physician” OR “health
professionals” OR “clinician” OR “clinic” OR “practi-
tioner” OR “general practitioner” OR “doctor”) AND
(“antibiotics” OR “antimicrobial”).
Based on previous reviews [14-17], we apply this selec-
tion criteria: (i) language: papers had to be published in
English, French, Spanish or Portuguese; (ii) type of inter-
vention: studies had to describe educational interven-
tions; (iii) target population: educational interventions
had to target physicians (general practitioners and all
specialties) and/or pharmacists (population studies were
included only if they also included interventions on
pharmacists and/or physicians); and (iv) outcome mea-
sures: studies had to measure the effect of educational
interventions on the prescribing behavior of physicians
and/or dispensing behavior of pharmacists. Insofar as
study design was concerned, no inclusion or exclusion
criteria were stipulated because our aim was to use




Adapted from Figueiras [18], study designs were classified
as follows: (1) before/after study; (2) non-randomizedcontrolled study without cross-contamination control; (3)
non-randomized controlled study with cross-contamination
control; (4) randomized controlled study without cross-
contamination control; and (5) randomized controlled
study without cross-contamination control. Where au-
thors reported the different groups as being in work-
places that were geographically far apart, the study
was deemed to have cross-contamination control; and
where no mention was made of distance between groups
or specific implementation of cross-contamination
control, the study was deemed to be without such
control.
Target disease
In cases where studies identified specific diseases in which
interventions were made to improve antibiotic use, this
was recorded.
Type of intervention
Educational interventions include any attempt to persuade
physicians to modify their practice performance by com-
municating clinical information strategies [19] and by
communication skills training [13]. Strategies that were
purely administrative or applied incentives or coercion
were excluded from this definition of educational inter-
ventions. In our review, we only included studies that
assessed educational interventions. However, in studies in
which these types of interventions were associated with
others, we extracted data on all strategies. Consequently,
interventions were classified into the following categories,
adapted from Davis [19] and Figueiras [18]: (1) dissemin-
ation of printed/audiovisual educational materials (mailed
printed matter; protocols and guidelines; self-instruction
materials; drug bulletins); (2) group education, including
group-session rounds, conferences, lectures, seminars,
and tutorials; (3) feedback of physician prescribing pat-
terns (individually, or including a comparison between
these patterns and peer behavior and/or accepted stan-
dards), or feedback of patient-specific lists of prescribed
medication; (4) individual outreach visits; (5) reminders at
the time of prescribing; (6) computer-assisted decision-
making systems; (7) formulary control/restrictive formu-
lary process; (8) patient education (pamphlets); (9) patient
education (videotapes); (10) workshops on rapid tests/
introduction of Rapid Antigen Detection Testing (RADT)
in consulting offices; (11) enforcement of regulations; (12)
prescription feedback, with recommendations to modify it
made by pharmacists and/or infectious-disease physicians;
(13) financial incentives.
Baseline and follow-up
Under this head, we included the period during which
outcomes were measured (baseline, intervention period
and follow-up).
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Studies were classified into different categories, namely:
(1) comparison of post-intervention values between
groups; (2) comparison of pre- and post-intervention
values within each group; (3) comparison of pre- and
post-intervention values between groups; (4) comparison
of follow-up values between groups; (5) comparison of
pre-, post, and follow-up values within each group; and,
(6) comparison of pre-, post- and follow-up values
between groups.
Statistical tests
We collected data yielded by statistical tests used to
assess the effectiveness of interventions.
Results
The results extracted from studies consisted of changes
in: total antibiotics prescribed/dispensed (T); choice of
appropriate antibiotics/adherence to antibiotic guidance
according to guideline algorithms, including dosages and
administration routes (Ga); attitudes and behavior (At/
Bh); quality of pharmacy practice (Qph).
Study results were classified as: positive (+), if reported
as positive or if changes in outcomes measured were
statistically significant; partially positive (±), if reported
as positive for some variables and negative for others;
and negative (−), if reported as negative.
Results and discussion
Selection of papers
The search yielded a total of 90,350 Abstracts, 47,535 of
which were potentially eligible for inclusion. A reading of
the titles and abstracts led to an initial selection of 571Figure 1 Identification and inclusion of studies.papers for full-text analysis; of these, 65 were then selected,
made up of 40 primary- and 25 hospital-care studies. After
a search of the references cited, 7 papers were added to the
primary-care and 6 to the hospital-care studies. A total of
78 papers were included, 47 primary- [20-66] and 31
hospital-care interventions [3,67-96] (Figure 1)
Interventions in primary care professionals
In the studies analyzed (Table 1), educational inter-
ventions in primary care mainly targeted physicians,
and outcomes were assessed by reference to the total
antibiotic prescription or appropriate antibiotic pre-
scription rates. Educational interventions in pharma-
cists occurred in 8 studies [25,32,33,42,44,50,52,66],
though in 6 cases the interventions covered both phar-
macists and physicians. In 21 studies [20,22,23,25,31-
33,35-37,39,43,45,46,50-53,55,57,60], the interventions
were extended to patients and their caregivers or
general population.
In primary care (table 2), 33 studies (70%) [20-24,
26,27,29,30,32-39,41,44,45,47,48,50,51,53,54,56,58-61,63,-
65] focused on the use of antibiotics in respiratory infec-
tions, and one focused on the use of antibiotics in
infectious diseases and other infections (urinary infec-
tions, skin and soft tissue infections and septicemia)
[27]; the remaining 30% failed to identify any target dis-
ease [25,28,31,40,42,43,46,49,52,55,57,62,64,66]. Of the
47 papers, 27 (57%) studied the efficacy/effectiveness of
one or more interventions versus non-intervention,
using a control group that received the intervention in
four studies, dissemination of guideline information in
three [56,57,65] and educational sessions on diagnosis of
otitis media in one [58]. In this last study, the educational
Table 1 Studies analyzing educational interventions in health professionals to improve antibiotic use
Author (year) Country Allocation unit (a) Intervention population (b) Type of patient Sample size (%) (b), (c) Statistical test
Dollman, WB (2005) [20] South Australia PC GPs, Pa All ___ Bivariate
Hrisos, S (2007) [21] UK PC GPs ___ 340 GPs Multivariate Bivariate
Hennessy, TW (2002) [22] USA (Alaska) PC Py, Pa, O All 3144 Pa Multivariate Bivariate
Rubin, MA (2005) [23] USA PC Py, Pa All ___ Multivariate
Naughton, C (2009) [24] Ireland PC GPs All 110 GPs Multivariate
Chazan, B (2007) [25] Israel (Northern) PC Py, Nu, Ph, Pa All 200 participants Bivariate
Briel, M (2005) [26] Switzerland PC Py Adults 45 Py Multivariate Bivariate
624 Pa
Monette, J (2007) [27] Canada PC Py Geriatric patients 36 Py Multivariate
Enriquez-Puga, A (2009) [28] England PC Py, GPs All 28 practices Multivariate Bivariate
Bjerrum, L (2006) [29] Spain PC GPs Adults 17 GPs in IG35 GPs in CG ___
Mcisaac, WJ (2002) [30] Canada PC GPs Children Adults 97 Py Multivariate Bivariate
621 patients
Wheeler, JG (2001) [31] USA PC Py, Pa Pediatric patients 16 Py Bivariate
771 parents
Juzych, NS (2005) [32] USA PC Py, Ps, Nu, Ph, Pa Adults Children 12 Py + 9 Ps in IG Univariate
6 Py + 9 Ps in CG
Smeets, HM (2009) [33] Netherlands PC GPs, Ph, Pa ___ 131 practices in IG Multivariate Bivariate
127 practices in CG
Mandryk, JA (2006) [34] Australia PC GPs ___ ___ Multivariate
Stille, CJ (2008) [35] USA PC Py, Pa Pediatric patients 168 Py Multivariate Bivariate
Finkelstein, JA (2001) [36] USA PC Py, Pa <6 years 14468 Pa (pre-) Multivariate Bivariate
13461 Pa (post-)
Altiner, A (2007) [37] Germany PC GPs, Pa ≥16 years 104 GPs (pre-) Multivariate
28 GPs + 787 Pa in CG
33 GPs + 920 Pa in IG
Légaré, F (2010) [38] Canada PC Py All 18 Py in IG + 15 Py in IG Multivariate
245 Pa in IG + 214 Pa In CG
Kiang, KM (2005) [39] USA PC Py, GPs, Ps, Nu, Pa, O Adults and pediatric patients 1800 Py Multivariate
Mohagheghi, MA (2005) [40] Iran PC GP Adults 40 GPs in CG ___
40 GPs in IG
Irurzun, C (2005) [41] Argentina PC Py ≥15 years 19 Py Bivariate



















Table 1 Studies analyzing educational interventions in health professionals to improve antibiotic use (Continued)
Finkelstein, JA (2008) [43] USA PC Py, Pa ≤6 years 223 135 person/years Multivariate
Chuc, NTK (2002) [44] Vietnam Pharmacy Ph ___ 58 pharmacies Bivariate
Belongia, EA (2001) [45] USA PC Ps, Pa Children 109 Py in IG Multivariate Univariate
52 in CG
Belongia, EA (2005) [46] USA PC Py, Ps, Pa ___ 12790 Py Multivariate Univariate
Greene, RA (2004) [47] USA PC Py, Ps Adults Children 900 Py and Pa Bivariate
Teng, CL (2007) [48] Malaysia PC GPs ___ 29 GPs Bivariate
Awad, AI (2006) [49] Sudan PC GPs ___ 1800 Pa Bivariate
Welschen, I (2004) [50] Netherlands PC GPs, Ph, Pa, O ___ 89 GPs Bivariate
Gonzales, R (2004) [51] USA PC Py, Pa, Elderly 51 office practice in CG Multivariate
4 office practices in IG
Colomina Rodríguez, J
(2010) [52]
Spain PC Py, Ph, Pa, O All ___ Bivariate
Hickman, DE (2003) [53] USA PC Py, Nu, Pa Adults ___ Bivariate
Children
Coenen, S (2004) [54] Belgium PC GPs Adults 42 GPs in IG Multivariate Bivariate
43 GPs in CG
Perz, JF (2002) [55] USA PC Py, Ps, Pa Pediatric patients 464200 person-years Multivariate
Sondergaard, J (2003) [56] Denmark PC Py ___ 299 GPs Bivariate
Doyne, EO (2004) [57] USA PC Ps, Pa Pediatric patients 6 practices - IG Multivariate
6 practices - CG
Bauchner, H (2006) [58] USA PC Ps Children (3–36 months) 1368 Pa - IG Multivariate Bivariate
1138 Pa - CG
Christakis, DA (2001) [59] USA PC Ps, Nu, O Children 16 providers - IG Bivariate
12 providers - CG
Smabrekke, L (2002) [60] Norway PC Ps, Nu, Pa Children (1–5 years) 819 Pa Bivariate
Bjerrum, L (2011) [61] Several PC GP Adults 47011 ___
Regev-Yochay, G (2011) [62] Israel PC GP Children 3636 Multivariate
Llor, C (2011) [63] Spain PC GP ___ 235 (full) Univariate Multivariate
97 (partial)
Weiss, K (2011) [64] Canada PC GP ___ All GP Multivariate
Llor, C (2011) [65] Spain PC GP Adults (14-60 years) 10 first patients ___
McKay, RM (2011) [66] Canada PC Py, Ph, O ___ ___ Bivariate



















Table 1 Studies analyzing educational interventions in health professionals to improve antibiotic use (Continued)
Chang, MT (2006) [67] Taiwan HC GPs ___ 5046 Pa (pre-) Bivariate
5054 Pa (post-)
Naughton, BJ (2001) [68] USA HC Py, Nu Geriatric patients 350 episodes Bivariate
Lutters, M (2004) [69] Switzerland HC Py Geriatric patients 3383 Pa Bivariate
Loeb, M (2005) [70] Canada and USA HC Py, Nu Geriatric patients 4217 residents Bivariate
Lesprit, P (2009) [71] France HC Py ___ 786 Pa Bivariate
Akter, SFU (2009) [72] Bangladesh HC Py Pediatric patients 2171 Pa (pre-) Bivariate
1295 Pa (post-)
Paul, M (2006) [73] Israel HC Py Adults 1203 Pa (pre-) Bivariate
Germany
Italy 2326 Pa (post-) (1245 IG and
1801 CG)
Camins, BC (2009) [74] USA HC Py (internists) ___ 784 new prescriptions Multivariate Bivariate
Westphal, JF (2010) [75] France HC Py ___ 471 cases of pneumonia 104
(pre-); 367 (post-)
Bivariate
Mullet, CJ (2001) [76] USA HC Ps, Nu Pediatric > 6 months 809 Pa (pre-) Bivariate
949 Pa (post-)
von Gunten, V (2005) [77] Switzerland HC Py ___ 1200 Pa Multivariate Bivariate
Ansari, F (2003) [78] UK HC Py ___ 40 medical and surgical wards Multivariate
Kisuule, F (2008) [79] USA HC Py, Nu ___ 17 hosp. practitioners Bivariate
Halm, EA (2004) [80] USA HC Py, Nu, Pa, O Adults 2094 cases Bivariate
1013 (pre-)
1081 (post-)
López-Medrano, F (2005) [81] Spain HC Py ___ 1280 treatments Bivariate
Agwu, AL (2008) [82] USA HC Py, Ps Children ___ Bivariate
Barenfanger, J (2001) [83] USA HC Pharmacy Ph ___ 378 Pa (188 IG and 190 CG) Bivariate
Rϋttiman, S (2004) [84] Switzerland HC Py Adults 500 Pa Bivariate
Martin, C (2005) [85] USA HC Py ___ ___ ____
Solomon, DH (2001) [86] USA HC Py ___ 4500 Pa Bivariate
Fowler, S (2007) [87] UK HC Py Elderly ≥ 80 years 6129 admissions Multivariate
Sintchenko, V (2005) [88] Australia HC Py ___ 12 internists Bivariate
Yong, MK (2010) [89] Australia HC Py ___ ___ Bivariate




















Table 1 Studies analyzing educational interventions in health professionals to improve antibiotic use (Continued)
Thursky, KA (2006) [91] Australia HC Py Adults 489 a (pre-) Multivariate
497 a (post-)
Petterson, E (2011) [92] Sweeden HC Nu, Py Elderly 60 sidents ___
Tangden, T (2011) [93] Sweeden HC Py elderly ___ Multivariate
Bivariate
Talpaert, MJ (2011) [94] UK HC Py Adults ___ Multivariate
Bevilacqua, S (2011) [95] France HC Py Adults ___ Bivariate
Shen, J (2011) [96] China HC Py Adults 354 atients Multivariate
Bivariate
(a) PC – primary care; HC – hospital care.
(b) GPs – general practitioners; Ps – pediatrics; Py – physicians; Pa – patients or their caregivers; Ph – pharmacists; Nu – nurses; O – others.






















Table 2 Interventions to improve antibiotic use in primary care
Author (year) Study
design (a)
Program description Baseline and follow-up Analysis
(e)
Results (f)
Disease (b) Intervention type
(c,d)
Baseline Intervention period Follow-up
Dollman, WB (2005) [20] 1 URTI IG: 1, 2, 8 5 months 5 months ___ 2 T (+)
CG: 0
Hrisos, S (2008) [21] 4 URTI IG1: 3 ___ 3 months ___ 3 At/Bh (+)
IG2: 3
IG1 + 2: 3
CG: 0
Hennessy, TW (2002) [22] 3 RTI IG: 8, 2 2 months 12 months (6 each
year of intervention)
2 months 2, 3 T (+)
CG: 0
Rubin, MA (2005) [23] 2 URTI IG: 1, 2, 8, 9 6 months 6 months ___ 2, 3 T (+)
CG: 0 Ga (+)
Naughton, C (2009) [24] 4 RTI IG1: 3, 4 12 months ___ 12 months 2, 3 T (+) (−)a
IG2: 3 Ga (+) (−)a
Chazan, B (2007) [25] 1 Infectious disease IG1: 1, 2 4 months 4 months ___ 2, 3 T (+)
IG2: 1, 2, 8
Briel, M (2005) [26] 4 ARTI IG1: 1,2 ___ 5 months ___ 1 T (+)
IG2: 1,2
CG: 0




Enriquez-Puga, A (2009) [28] 4 ___ IG: 1, 3, 4 2 periods of
6 months
6 months 24 months 5, 6 Ga (−)
Bjerrum, L (2006) [29] 2 RTI IG: 2, 3, 10 3 weeks during
3 months
3 weeks during 3 months ___ 1, 2 T (+)
CG: 0 Ga (+)
Mcisaac, WJ (2002) [30] 4 Sore throat IG: 1, 5 ___ ___ ___ 1 T (−)
CG: 0 Ga (−)
Wheeler, JG (2001) [31] 1 Viral infections IG: 2, 8, 9 1 week 3 weeks during 3 years 6 months (qualitative) 3 T (−)
At/Bh (+)
Juzych, NS (2005) [32] 3 URTI IG: 1, 2, 8 4.5 months 4.5 months ___ 2, 3 Pa (+) (−)b
CG: 0 T (+)























Mandryk, JA (2006) [34] 1 URTI IG: 1, 2, 3, 4 33 months 51 months ___ 2 Ga (+)
T (+)
Stille, CJ (2008) [35] 4 RTI IG: 1, 2, 8 — — 6 months 1 At/Bh (+) (−)c
CG: 0





Altiner, A (2007) [37] 4 Acute cough IG: 4, 8 3 months ___ 3 months after
6 weeks 3 months
after 1 year after
5, 6 T (+)
CG: 0
Légaré, F (2010) [38] 4 Acute RI IG: 1, 2 ___ ___ ___ 2, 3 T (+)
CG: 0
Kiang, KM (2005) [39] 1 Respiratory
illnesses
IG: 1, 2, 8 ___ ___ ___ 2, 3 Ga (+)
At/Bh (+)
Mohagheghi, MA [40] 4 ___ IG: 2 60 months ___ 3 months afterwards
1 year afterwards
2, 3 T (+) (−)d
CG: 0
Irurzun, C (2005) [41] 1 Pharyngitis and
tonsillitis
IG: 1, 2, 3, 4, 10 ___ 12 months ___ 2 T (+)
Ga (+)
Chalker, J (2005) [42] 5 ___ IG: 2, 4, 11 ___ ___ 3x3 months (one
month after each
intervention)
1 T (+) (−)e
CG: 0
Finkelstein, JA (2008) [43] 4 ___ IG: 1, 2, 3, 8 24 months 6 months during
3 years
___ 2, 3 T (+) (−)f
CG: 0 Ga (+)
Chuc, NTK (2002) [44] 4 ARTI IG: 2, 4, 11 ___ ___ ___ 2, 3 T (+)
Qh (+)
Belongia, EA (2001) [45] 3 ARTI IG: 1, 2, 8 6 months ___ 6 months (every
two years)
7, 8 T (+)
Belongia, EA (2005) [46] 2 ___ IG: 1, 2, 8, 9 12 months 48 months ___ 3, 4 T (+) (−)g
Greene, RA (2004) [47] 1 Acute sinusitis IG: 1, 2, 3, 13 22 months 14 months ___ 2 Ga (+)
T (+)



















Table 2 Interventions to improve antibiotic use in primary care (Continued)
Awad, AI (2006) [49] 4 ___ CG: 0 ___ ___ 1 and 3 months
afterwards
2, 3 T (+)h
IG1: 1, 3 Ga (+)
IG2: 2, 3
IG3: 3, 4
Welschen, I (2004) [50] 4 ARTI IG: 1, 2, 3, 8 3 months ___ 3 months 2, 3 T (+)
Gonzales, R (2004) [51] 2 ARTI IG: 1, 8 4 months 4 months (study period) 2, 3 T (+) (−)i
Colomina Rodríguez, J (2010) [52] 1 ___ IG: 1, 2, 6, 8 48 months 36 months 24 months 5 T (+)
Ga (+)
Hickman, DE (2003) [53] 4 Acute bronchitis IG: 1, 2, 8 6 months ___ 6 months 2, 3 T (+)
CG: 0
Coenen, S (2004) [54] 4 Acute cough IG: 1, 4 3 months 1 month (without
outcomes)
___ 2,3 T (+)
IG: 0 Ga (+) (−)j
Perz, JF (2002) [55] 1 ___ IG: 1, 2, 8, 9 12 months 12 months 12 months 5,6 T (+)
CG: 0
Sondergaard, J (2003) [56] 4 RTI IG: 1, 3 3 periods of
3 months
3 periods of 3 months 3 months
(not shown)
2,3 T (−)
CG: 1 Ga (−)
Doyne, EO (2004) [57] 4 ___ IG: 1, 2, 3, 8 12 months 12 months ___ 2,3 T (+) (−)k
CG1: 1, 3
CG: 1
Bauchner, H (2006) [58] 5 Acute otitis
media
IG: 1, 2, 3 ___ ___ ___ 1 Ga (+) (−)L
CG: 2
Christakis, DA (2001) [59] 4 Acute otitis
media
IG: 6 7 months 8 months ___ 2,3 T (−)
CG: 0 Ga (+)
Småbrekke, L (2002) [60] 2 Acute otitis
media
IG: 1, 2, 8 4 months 4 months ___ 2,3 T (+)
CG: 0 Ga (+)
Bjerrum, L (2011) [61] 1 RTI IG = 2, 3, 9, 10 3 weeks
(x2years)
3 weeks (x1 year) ___ 2, 3 T (+)
Ga (+)
Regev-Yochay, G (2011) [62] 4 ___ IG = 2 2 years 1 year ___ 2, 3 T (+)
CG = 0 Ga (+)
Llor, C (2011) [63] 4 Pharyngitis IG1 = 2, 8, 10 15 days 15 days ___ 2, 3 T (+)
IG2 = 2, 8, 10
(sem)




















Table 2 Interventions to improve antibiotic use in primary care (Continued)
Llor, C (2011) [65] 4 Acute
pharyngitis
IG = 1, 10 ___ ___ ___ 1 Ga (+)
CG = 1
McKay, RM (2011) [66] 1 ___ IG = 1, 2, 8, 9 9 years 3 years ___ 2 Pa (+) (−)m
aIn[24], significantly positive in post-intervention period but no significant change post-follow-up.
bIn [32], while prescriptions for pharyngitis, otitis media and URTI decreased significantly post-intervention, the decrease in the case of bronchitis was not as significant.
cIn [35], comparison between attitudes, knowledge and behavior of physicians in the intervention versus the control group showed no significant differences. Physicians in the intervention group reported that they had
changed their prescribing in the preceding 3 years.
dIn [40], after one year, there was a reduction in the percentage of antibiotic prescribing in the intervention group but this was not statistically different from the control group.
eIn [42], interventions resulted in improved antibiotic use, which was statistically significant in the Hanoi but not in the Bangkok study.
fIn [43], there was no significant decrease in one age group (3–24 months).
gIn [56], the reduction in antibiotic prescribing by pediatricians was greater in the control than in the intervention group.
hIn [49], audit and feedback combined with academic detailing or seminars appeared to be more effective in changing antibiotic prescribing practices than audit and feedback alone.
iIn [51], there was a moderate decrease in total antibiotics prescribed but this was not statistically significant.
jIn [54], appropriate antibiotic prescribing improved post-intervention but did not prove statistically significant.
kIn [57], the prescribing rate decreased in all groups but there were no statistically significant differences between groups.
LIn [58], adherence was high though not statistically significant in the intervention group, but, in second episodes there were no differences in adherence, between groups.
mIn [66], utilization rates for acute bronchitis are at the same level as when intervention began, but other acute respiratory tract infections declined.
(a) Disease: URTI – upper respiratory tract infections; RTI – respiratory tract infections; ARTI – acute respiratory tract infections; UTI – urinary tract infections.
(b) Study design (SD): (1) before/after studies; (2) – nonrandomized controlled trial without cross-contamination control; (3) – nonrandomized controlled trial with cross-contamination control; (4) - randomized
controlled trial without cross-contamination control; (5) - randomized controlled trial with cross-contamination control.
(c) IG – intervention group; CG – control group.
(d) Type of intervention (TI): (0) no intervention; (1) dissemination of printed/audiovisual educational materials (mailed printed matter; protocols and guidelines; self-instruction materials; drug bulletins); (2) group
education, including group-session rounds, conferences, lectures, seminars and tutorials; (3) feedback of physician prescribing patterns (individually or including a comparison of these patterns with peer behavior and/
or accepted standards) or feedback of patient-specific lists of prescribed medication; (4) individual outreach visits; (5) reminders at the time of prescribing; (6) computer-assisted decision-making systems; (7) formulary-
control/restrictive formulary process; (8) patient education (pamphlets); (9) patient education (videotapes); (10) workshops on rapid tests / introduction of Rapid Antigen Detection Tests (RADTs) in consulting offices;
(11) enforcement of regulations; (12) prescription feedback with recommendations to modify it by pharmacists and/or infectious-disease physicians; (13) financial incentives.
(e) Type of data-analysis (T): (1) comparison of post-test values between groups; (2) comparison of pre- and post-values within each group; (3) comparison of pre- and post-values between groups; (4) comparison of
follow-up values between groups; (5) comparison of pre-, post- and follow-up values within each group; (6) comparison of pre-, post- and follow-up values between groups.
(f) Results analyzed (R): (T) total antibiotics prescribed/dispensed; (Ga) choice of appropriate antibiotics/adherence to antibiotic guidance according to guideline algorithms, including dosages and routes of























Program description Baseline and follow-up Analysis (d) Results (e)
Disease Intervention type (b, c) Baseline Intervention period Follow-up
Deuster, S (2010) [3] 1 Most common hospital infections IG: 1, 2 8 weeks 8 weeks 8 weeks (1 year after) 5 Ga (+) (−)a
Chang, MT (2006) [67] 1 ___ IG: 1, 7 3 months 3 months ___ 2 T (+)
Ga (+)
Naughton, BJ (2001) [68] 4 Pneumonia IG: 1, 2 6 months 6 months ___ 2, 3 T (−)
CG: 1, 2
Lutters, M (2004) [69] 1 RTI and UTI IG: 1, 2, 4 12 months 24 months ___ 2 T (+)
Ga (+)
Loeb, M (2005) [70] 4 UTI IG: 1, 2, 4 ___ ___ ___ 1 T (+)
CG: 0
Lesprit, P (2009) [71] 2 Various IG: 1, 2, 12 ___ 8 weeks ___ 1 Ga (+)
CG: 1, 2
Akter, SFU (2009) [72] 2 Common pediatric infections IG: 2 4 months 4 months ___ 2, 3 T (+)
Ga (+)
Paul, M (2006) [73] 5 ___ IG: 6 7 months 7 months ___ 1, 2 Ga (+)
CG: 0
Camins, BC (2009) [74] 4 ___ IG: 1, 3, 4 ___ 10 months ___ 1 Ga (+)
CG: 1 (guidelines)
Westphal, JF (2010) [75] 1 Pneumonia IG: 2, 5, 6 18 months 54 months ___ 2 Ga (+) (−)b
Mullet, CJ (2001) [76] 1 ___ IG: 6 6 months 6 months ___ 2 T (+) (−)c
Ga (+)
von Gunten, V (2005) [77] 5 ___ IGB: 1 6 months 6 months ___ 2, 3 T (+)
IGC: 1, 2, 12 Ga (+)
CGA: 0
Ansari, F (2003) [78] 1 ___ IG: 12 24 months 24 months ___ 2 Ga (+) (−)d
T (+)
Kisuule, F (2008) [79] 1 ___ IG: 1, 3, 4 Period until 20 prescriptions 2 months 1 month 2 Ga (+)
Halm, EA (2004) [80] 1 Pneumonia IG: 1, 2, 8, 9 5 months — 5 months 2 Ga (+)
López-Medrano, F (2005) [81] 1 ___ IG: 12 12 months 12 months ___ 2 T (+)
Ga (+)
Agwu, AL (2008) [82] 1 ___ IG: 6, 12 12 months 12 months ___ 2 Ga (+)
Barenfanger, J (2001) [83] 4 ___ IG: 6 ___ 5 months ___ 1 T (+)
CG: 0



















Table 3 Interventions to improve antibiotic use in hospital settings (Continued)
Martin, C (2005) [85] 1 Pneumonia IG: 1, 2 ___ 60 months ___ 2 Ga (+)
Meningitis
UTI
Solomon, DH (2001) [86] 4 ___ IG: 1, 3, 4, 12 4 weeks 18 weeks ___ 2, 3 Ga (+)
CG: 0
Fowler, S (2007) [87] 1 ___ IG: 1, 3 21 months 21 months ___ 2 Ga (+)
Sintchenko, V (2005) [88] 1 Intensive care IG: 6 6 months 6 months ___ 2 T (+) Ga (+)
Yong, MK (2010) [89] 1 Intensive care IG: 6 30 months 54 months ___ 2 Ga (+)
Meyer, E (2010) [90] 1 Intensive care IG: 2 24 months 36 months ___ 2 T (+)
Thursky, KA (2006) [91] 1 Intensive care IG: 2, 6 6 months 6 months ___ 2 T (+) Ga (+)
Petterson, E (2011) [92] 4 UTI IG = 1, 2, 3 3 months 3 months 2, 3 T (+)
CG = 0 Ga (+)
Tangden, T (2011) [93] 1 Pneumonia (Intravenous) IG = 1, 2 7 years 2.5 years 3 T (+)
Ga (+) (−)e
Talpaert, MJ (2011) [94] 1 ___ IG = 2 12 months 12 months 3 T (+) (−)f
Bevilacqua, S (2011) [95] 2 ___ IG = 3, 7, 12 12 months 12 months 2, 3 Ga (+)
CG = 0
Shen, J (2011) [96] 2 Bronchitis IG = 12 10 months 1 Ga (+)
Community acquired pneumonia CG = 0
Acute exacerbation of COPD
aIn [3], the follow-up analysis showed sustained adherence to guidelines in hospital-acquired pneumonia but a decrease in guideline adherence in the case of UTI.
bIn [75], there was a significant decrease in the proportion of antibiotic orders containing at least one criterion that was not in line with the guideline, but the choice of antibiotics according to the context of acquisition of
pneumonia, improvement was not statistically significant.
cIn [76], total of antibiotics used was similar but the number of orders placed per antibiotic course decreased post-intervention.
dIn [78], there was a significant decrease in use of total and alert antibiotics, except in the case of ceftriaxone and mercapen.
eIn [93], there was a reduction of cefalosporines consumption, but pipiracillin/tazobactan and penicillin increased
fIn [94], there was a reduction in fluorquinolone and cefalosporine but no significant change total of antibiotics neither clindamicine, amoxiciline and co-amoxclav use.
(a) Disease: URTI – upper respiratory tract infections; RTI – respiratory tract infections; ARTI – acute respiratory tract infections; UTI – urinary tract infections; COPD-Chronic obstructive pulmonary disease.
(b) Study design (SD): (1) before/after studies; (2) – nonrandomized controlled trial without cross-contamination control; (3) – nonrandomized controlled trial with cross-contamination control; (4) - randomized
controlled trial without cross-contamination control; (5) - randomized controlled trial with cross-contamination control.
(c) IG – intervention group; CG – control group.
(d) Type of intervention (TI): (0) no intervention; (1) dissemination of printed/audiovisual educational materials (mailed printed matter; protocols and guidelines; self-instruction materials; drug bulletins); (2) group
education, including group-session rounds, conferences, lectures, seminars and tutorials; (3) feedback of physician prescribing patterns (individually or including a comparison of these patterns with peer behavior and/
or accepted standards) or feedback of patient-specific lists of prescribed medication; (4) individual outreach visits; (5) reminders at the time of prescribing; (6) computer-assisted decision-making systems; (7) formulary-
control/restrictive formulary process; (8) patient education (pamphlets); (9) patient education (videotapes); (10) workshops on rapid tests / introduction of Rapid Antigen Detection Tests (RADTs) in consulting offices;
(11) enforcement of regulations; (12) prescription feedback with recommendations to modify it by pharmacists and/or infectious-disease physicians; (13) financial incentives.
(e) Type of data-analysis (T): (1) comparison of post-test values between groups; (2) comparison of pre- and post-values within each group; (3) comparison of pre- and post-values between groups; (4) comparison of
follow-up values between groups; (5) comparison of pre-, post- and follow-up values within each group; (6) comparison of pre-, post- and follow-up values between groups.
(f) Results analyzed (R): (T) total antibiotics prescribed/dispensed; (Ga) choice of appropriate antibiotics/adherence to antibiotic guidance according to guideline algorithms, including dosages and routes of
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http://www.biomedcentral.com/1471-2458/14/1276session in the intervention group included diagnosis of
otitis media and information on recommendations for
antibiotic use.
Only two studies [51,64], evaluated the efficacy of pas-
sive interventions in physicians and in one of them inter-
ventions was in combination with educational campaigns
directed at patients and their caregivers [51]. All the
other studies included active interventions in health
professionals (whether or not associated with passive
interventions). Three studies [22,46,66], involved active
interventions in patients and health professionals, and
in four studies [26,33,50,62] the interventions included
improvement of doctor-patient communication skills.
Twenty-nine studies (62%) [20-23,25-27,29,34,36-39,
41,44,45,47-50,52,53,55,60-65] reported positive results
for all outcomes measured; fourteen studies (30%)
[24,31,32,35,40,42,43,46,51,54,57-59,66] reported positive
results for some outcomes, and results that were not sta-
tistically influenced by the intervention for others; only
four studies [28,30,33,56] failed to report significant
post-intervention improvements for all outcomes.
While some studies conducted no post-intervention
follow-up of participants [20,21,23,25,26,29,30,32,34,36,
38,39,41,43,44,46,47,54,57-66], others followed up their
participants for different periods, ranging from two
months [22] to three [27,37,40,42,48-50,56], six [31,
33,35,45,53], twelve [24,55] and twenty-four months
[28,52].
Interventions that included improving diagnostic
procedures to help physicians distinguish bacterial from
viral infections led to very positive results [29,41,61,
63,65].
Interventions in hospital care professionals
Whereas most interventions concentrated on physicians
(Table 1), some included a multidisciplinary intervention
targeting physicians and nurses [68,70,76,79,92], patients
[80], and in one case, solely pharmacists [83]. Some
studies identified the patients targeted, with these being
elderly in five instances [68-70,87,92,93] children in
three [72,76,82]. Table 3 summarizes the studies re-
trieved containing interventions for improving antibiotic
use in hospital care. The diseases targeted were as
follows: pneumonia in four cases [68,75,80,93]; urinary
infections in two [70,72]; urinary and upper respiratory
tract infections in one [69]; pneumonia, meningitis and
urinary infection in one study [85], and bronchitis, com-
munity acquired pneumonia and chronic obstructive
pulmonary disease in other [96]. Of the thirty-one pa-
pers, 6 (20%) studied the efficacy/effectiveness of one or
more interventions versus no intervention, using a con-
trol group [70,71,73,77,83,86]. Naughton [68] compared
two strategies, a multidisciplinary intervention in physi-
cians and nurses, and a physician-only intervention in tenskilled nursing facilities randomized into two groups,
and reported no statistically significant differences
between the two groups. Most of the reported hospital-
based interventions coincided with the implementa-
tion of protocols or new computer systems, with the
result that post-intervention were compared with
pre-intervention outcomes without the use of control
groups.
While some studies [67,73,76,83,87-89] used passive
interventions, all the others used active interventions or
passive and active simultaneously. Twenty-four papers
(78%) [67,69-74,77,79-92,95,96] reported positive results
for all outcome measures; 6 papers (20%) [3,75,76,
78,93,94] reported some outcomes as positive and others
as positive statistically non-significant; and Naughton
reported negative results [68].
In contrast to primary care in which only three studies
[24,26,32] analyzed clinical outcomes, in hospital care
some studies [67,69,70,72,74,81,84,86,96] compared out-
comes pre- and post-intervention to assess whether a re-
duction in antibiotic use might cause clinical alterations,
and no influences were observed, namely, to length of
hospital stay, and mortality, morbidity and/or readmis-
sion rates.
Many of the hospital-care studies highlighted the im-
portant role of clinical pharmacists in drawing up and
implementing guidelines and policies for antibiotic use
in hospital settings [3,67,69,74,75,77-80,82,85,86,91,96].
Studies design
While 25 papers (53%) [21,24,26-28,30,35-38,40,42-44,
49,50,53,54,56-59,62,63,65] reported randomized con-
trolled studies in the case of primary care, a far lower
number, i.e., 8 (26%) [68,70,73,74,77,83,86,92], reported
this type of study in the case of hospital care, and only
one of these included cross-contamination control.
Cross-contamination can occur when the participants of
different intervention or control groups have close work-
ing relationships and might share information about the
intervention, and this is important because differences in
the results between the intervention and the control
group may be influenced by this factor. In some studies
physicians participated on a voluntary basis (they were
invited to participate in the study), and their prescribing
habits recorded during the intervention may not repre-
sent their real use of antibiotics [24,26-30,33,37,50,
61-63,65,70].
There were many differences in the analytical ap-
proaches adopted by the different studies: while some
compared the results of the intervention with the situation
at baseline, and some compared the results between
groups pre- and post-intervention, others focused exclu-
sively on the position post-intervention. There were few
studies that conducted a follow-up after the intervention
Table 4 Review studies covering interventions to improve antibiotic use







improve antibiotic use for
respiratory tract infections
To assess the effectiveness of
physician-targeted interventions aiming
to improve antibiotic prescribing for
respiratory tract infections in primary
care, and to identify intervention
features mostly contributing to
intervention success.
Studies with an intervention primarily
targeted at physicians in a primary care
setting aiming to improve antibiotic
prescribing for RTIs, conducted in a
high-income country, presenting a
standardized outcome of (first choice)
prescription measured in defined daily
dosage,
prescription or rates.
Systematic review of studies
published in MEDLINE, EMBASE,
and the Cochrane Library.
Quantitative analysis to assess the
association between effectiveness






Behaviour Change Strategies to
Influence Antimicrobial
Prescribing in Acute Care: A
Systematic Review
To assess the effectiveness of
antimicrobial prescribing interventions
that either alone or in combination,
aim to influence behaviors in acute
care.
Effective Practice and Organization of
Care (EPOC) model was adapted to
include additional criteria for review of
uncontrolled studies. Studies were
included only if they were conducted
in countries defined as having a
developed health care system.
Systematic review of studies
published in MEDLINE, Applied
Social Sciences Index and Abstracts
(ASSIA), Business Source Complete,
The Cochrane Library, PsycINFO,
and the Database of Abstracts of








Antibiotic prescribing for acute
respiratory tract infections in
primary care: a systematic
review and meta-ethnography.
To evaluate general practitioners’
perceptions about antibiotic
prescribing, and interventions aimed at
prudent prescribing.
Studies that used qualitative methods
and analysis.
Meta-synthesis of qualitative
research examining GP attitudes
and experiences of antibiotic
prescribing, and interventions
aimed at more prudent prescribing
for ARTI.
12 1950-May 2011
Kaki, R (2011) [11] Impact of antimicrobial
stewardship in critical care: a
systematic review.
To evaluate the evidence for
antimicrobial stewardship interventions
in the critical care unit.
Studies that evaluate the effectiveness
of application of any intervention to
improve antimicrobial utilization and
within an intensive care setting, using
a modified Cochrane Registry EPOC
Database inclusion criteria.
Systematic review of studies
published in OVID MEDLINE,






Interventions in health care
professionals to improve
treatment in children with
upper respiratory tract
infections.
To analyze which strategies are used to
promote evidence-based interventions
in the management of children with
URTI and assess the related
effectiveness and costs.
Randomized controlled trials, non-
randomized controlled trials and
controlled before/after studies using
implementation methods to change
health care professionals’ attitudes to
the treatment of children with URTI
and investigate the effectiveness of
implementation strategies.
Systematic review of studies
published in Pubmed, Embase and







A systematic review and
quantitative analysis of quality
improvement strategies.
To assess which interventions are most
effective in improving the prescribing
of recommended antibiotics for acute
outpatient infections.
Clinical trials with contemporaneous or
strict historical controls that reported
data on antibiotic selection in acute
outpatient infections
Systematic review with quantitative
analysis of the EPOC Database,
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of positive results observed in the post-intervention period
were lost over time.
No studies were found in which the interventions had
been designed on the basis of the attitudes and behav-
ior responsible for antibiotic prescribing or dispensing
habits, despite the fact that many authors contend that
this knowledge contributes to the success of educa-
tional interventions in health professionals [69,79,80].
In some studies [28,33,49,79], however, interventions
addressed barriers facing the individual prescriber, par-
ticularly when it came to dealing with diagnostic uncer-
tainty, and were tailored to: overcoming any identified
barriers and enable general practitioners (GPs) to re-
flect on their own prescribing; helping decrease uncertainty
about appropriate disease management and appropriate
prescribing; facilitating more patient-centered care; and be-
ing beneficial to implementation in practice. One study [39]
assessed the impact of interventions on the knowledge, be-
liefs, and decision-making of primary care physicians, and
two others, used workshops and focus-group discussions to
determine the possible motivating factors underlying ob-
served prescribing practices [49,62]. The importance of in-
terventions being acceptable to physicians was highlighted
by a recent systematic review [97].
All the studies underlined the importance of appro-
priate use of antibiotics to prevent the problem of mi-
crobial resistance, and stated that the most important
aim of interventions to improve antibiotic use was to
reduce this important public health problem. Even so,
only one primary-care [46] and eight hospital-care studies
[67,84,85,87,89-91,93] analyzed improvement in bacterial
susceptibility during the intervention. While some studies
reported the reduction in the cost of antibiotic use, only
five studies analyzed the effectiveness of intervention in
terms of the cost of the intervention versus the cost of re-
ducing antibiotic use [73,78,81,84,86,96].
We found only two studies that addressed interven-
tions (undertaken in Thailand and Vietnam, respectively)
[42,44] specifically designed to improve pharmacists’ to
combat the dispensing of antibiotics without prescrip-
tion, despite there were studies which established that
the sale of antibiotics without a prescription are a reality
in some European countries [98-102]. Although some of
the studies reviewed -mainly those pertaining to hospital
care- reported the important role played by pharmacists
in developing interventions to be undertaken in physi-
cians and implementing antibiotic treatment guidelines
and protocols in hospital settings, there were few studies
with interventions targeted at pharmacists. Some au-
thors stressed the usefulness of including pharmacists in
teams tasked with drawing up recommendations and
making decisions about antibiotic use in certain coun-
tries [54,96,103,104].Results obtained by our search showed that the major-
ity of published studies about educational interventions
describe active and multifaceted interventions. This find-
ing is in accordance with a number of systematic meta-
analyses of randomized controlled trials to improve
health care practice, which conclude that highly inter-
active learning methods, such as educational outreach
visits [105] workshops [106,107], small discussion groups
[107,108], individualized training sessions [107,108],
practice-based interventions [19] and case-based learn-
ing [109], are the most effective strategies.
Some recent review papers on interventions to im-
prove antibiotic prescribing [9-11,97] (Table 4) focus on
a limited set of intervention targets, such as acute out-
patient infections, and more specifically on clinical
knowledge and decision-making processes [9], specific
populations (children), specific diseases (upper respira-
tory tract infections) [10] or purpose-designed nonedu-
cational (stewardship) interventions in specific hospital
divisions, such as critical care [11] and acute care [12].
One paper [97] reviewed studies that evaluated GPs’ per-
ceptions about antibiotic prescribing and interventions
aimed at prudent prescribing. Our study only analyzed
educational interventions but was more extensive, in
that it included interventions aimed at physicians and/
or pharmacists in both primary-care and hospital set-
tings, and focused on any disease with antibiotic prescrib-
ing for child, adult or geriatric patients. In contrast to
Steinman [9], who made a quantitative analyses of
quality-improvement strategies, our review, like those
of Boonacker [10], Kaki [11] and Charani [12], was a
qualitative analysis.
As in the case of any systematic review, ours suffers
from the limitation of publication bias. The inclusion
criteria allowed for the review to cover a wide range of
studies with different designs, something hindered us in
making comparisons and performing a meta-analysis.
Identification of the design proved a complex task, and it
is therefore possible that some study may have been mis-
classified as regards design, due to an incomplete descrip-
tion of the methodology used. In many cases, deficiencies
in the design and description of the intervention and iden-
tification of the sample made tabulating the study charac-
teristics difficult.
Conclusions
The results yielded by our search show that there are
many more papers on educational interventions in phy-
sicians than pharmacists. Respiratory disorders were the
disease targeted by most studies, mainly in primary care.
Published studies varied widely in terms of study design,
outcome measures, outcome period, and definition of
sample. Most studies used active or a mix of active
and passive interventions, and reported that active
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http://www.biomedcentral.com/1471-2458/14/1276interventions were more effective. Notwithstanding
these heterogeneity, it can be concluded from the above:
first, that educational interventions to improve antibiotic
use are essential; and second, that in many studies such
interventions are active and multifaceted, some of them
include both physicians and pharmacists, and were de-
signed taking these health professionals’ attitudes and
knowledge into account, in order to focus on the barriers
so identified.
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